Cargando…
Gene therapy for neuropathic pain using dorsal root ganglion–targeted helper-dependent adenoviral vectors with GAD67 expression
INTRODUCTION: Currently available medications for neuropathic pain are of limited efficacy. Moreover, they are administered systemically and are associated with significant side effects. Ideally, one can circumvent systemic side effects if such treatment can be administered by delivery of the therap...
Autores principales: | Ogawa, Nobuhiro, Terashima, Tomoya, Oka, Kazuhiro, Chan, Lawrence, Kojima, Hideto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344132/ https://www.ncbi.nlm.nih.gov/pubmed/30706038 http://dx.doi.org/10.1097/PR9.0000000000000695 |
Ejemplares similares
-
Gene Therapy for Neuropathic Pain by Silencing of TNF-α Expression with Lentiviral Vectors Targeting the Dorsal Root Ganglion in Mice
por: Ogawa, Nobuhiro, et al.
Publicado: (2014) -
Expression of GAD67 and Novel GAD67 Splice Variants During Human Fetal Pancreas Development: GAD67 Expression in the Fetal Pancreas
por: Korpershoek, Esther, et al.
Publicado: (2007) -
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
por: Li, Rongying, et al.
Publicado: (2012) -
Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia
por: Terashima, Tomoya, et al.
Publicado: (2018) -
Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by
balloon-catheter hepatic delivery of helper-dependent adenoviral vector
por: Oka, Kazuhiro, et al.
Publicado: (2014)